With the conclusion of the International Summit on Human Gene Editing, the second component of the Initiative began: a study of the scientific underpinnings of human gene-editing technologies, their potential use in biomedical research and medicine — including human germline editing — and the clinical, ethical, legal, and social implications of their use. Read the results of this study now. Committee includes our Jeffrey Kahn

Quick Read

One-year-old girl treated as plans to inject DNA-cutting technology directly into patients’ bodies take shape

Quick Read